Formulating and developing effective transdermal products has always proven a complex and difficult task. Until now.
By offering a combination of licensing and direct manufacture, Greene Street are well positioned to help benefit the lives of patients and physicians, while unleashing a sizeable pipeline of attractive products for the industry.
With early stage products ready for license Greene Street continues to move our developed product through animal and human clinical studies. Our Transdermal Innovative Products:
comparative oral drug specifications
to or even exceed the current FDA rules and guidelines
the majority of side effects encountered in oral drugs
reduce the potential for abuse, addiction
Our development arm has a laser focus on the formulation of TiPs, creating robust product development processes, and the identification of high-revenue potential products which can be licensed, taken to market, and scaled effectively.
Our manufacturing arm offers a range of capabilities, with a focus on producing products that our development arm formulate for licensing partners. We go beyond proof of concept and can ramp production up to multi-millions of patches/ year scale as required.
Product Development, Licensing, In-house Development, and Manufacturing blend seamlessly at Greene Street, and enable us to offer you a full spectrum of transdermal related services.
With over a dozen products in final or near final stage of development or testing, our portfolio is extensive, expanding rapidly and available immediately for licensing or manufacture.